CAM
NVO

Cozad Asset Management’s Novo Nordisk NVO Stock Holding History

Cozad Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+4,680
New +$201K 0.01% 423
2026
Q1 		– Sell
-6,019
Closed -$306K – 431
2025
Q4 		$306K Sell
6,019
-3,457
-36% -$177K 0.02% 348
2025
Q3 		$526K Sell
9,476
-803
-8% -$47K 0.04% 294
2025
Q2 		$709K Sell
10,279
-4,010
-28% -$273K 0.06% 242
2025
Q1 		$992K Sell
14,289
-4,609
-24% -$381K 0.1% 194
2024
Q4 		$1.63M Sell
18,898
-5,003
-21% -$541K 0.15% 148
2024
Q3 		$2.85M Buy
23,901
+3,020
+14% +$403K 0.27% 96
2024
Q2 		$2.98M Buy
20,881
+4,463
+27% +$591K 0.3% 92
2024
Q1 		$2.11M Buy
16,418
+1,248
+8% +$149K 0.22% 119
2023
Q4 		$1.57M Buy
15,170
+4,288
+39% +$424K 0.18% 135
2023
Q3 		$990K Buy
10,882
+1,268
+13% +$112K 0.13% 175
2023
Q2 		$778K Sell
9,614
-690
-7% -$56.4K 0.1% 194
2023
Q1 		$820K Sell
10,304
-72
-0.7% -$5.11K 0.11% 187
2022
Q4 		$702K Sell
10,376
-72
-0.7% -$4.22K 0.1% 203
2022
Q3 		$520K Hold
10,448
– – 0.08% 211
2022
Q2 		$582K Sell
10,448
-380
-4% -$21.1K 0.09% 198
2022
Q1 		$601K Buy
10,828
+280
+3% +$14.4K 0.08% 209
2021
Q4 		$591K Hold
10,548
– – 0.08% 198
2021
Q3 		$506K Hold
10,548
– – 0.08% 209
2021
Q2 		$442K Hold
10,548
– – 0.07% 229
2021
Q1 		$356K Sell
10,548
-360
-3% -$12.8K 0.06% 252
2020
Q4 		$381K Hold
10,908
– – 0.07% 233
2020
Q3 		$379K Hold
10,908
– – 0.07% 226
2020
Q2 		$357K Hold
10,908
– – 0.07% 227
2020
Q1 		$328K Hold
10,908
– – 0.11% 153
2019
Q4 		$316K Sell
10,908
-420
-4% -$11.6K 0.08% 189
2019
Q3 		$293K Hold
11,328
– – 0.08% 199
2019
Q2 		$289K Hold
11,328
– – 0.08% 195
2019
Q1 		$296K Sell
11,328
-136
-1% -$3.34K 0.09% 192
2018
Q4 		$264K Buy
11,464
+72
+0.6% +$1.6K 0.09% 195
2018
Q3 		$269K Sell
11,392
-3,400
-23% -$83K 0.08% 195
2018
Q2 		$341K Buy
+14,792
New +$352K 0.11% 161

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cozad Asset Management's NVO Position: Q2 2026 in Review

Cozad Asset Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,680 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #423 among its holdings. This is a return to the name: Cozad Asset Management previously reported a position in NVO as recently as Q4 2025.

Cozad Asset Management first reported a position in NVO in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.98M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cozad Asset Management held 4,680 shares of Novo Nordisk worth $224K as of Q2 2026.
  • Novo Nordisk was a new Cozad Asset Management position in Q2 2026.
  • Novo Nordisk made up 0.01% of Cozad Asset Management's portfolio in Q2 2026, its #423 holding.
  • Cozad Asset Management first reported a position in Novo Nordisk in Q2 2018 and has held it in 32 quarters since.
  • Cozad Asset Management's Novo Nordisk position peaked at $2.98M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.